Streptococcus pneumoniae related diseases are a leading cause of morbidity and mortality,
especially in children and in the elderly population. It is transmitted to other individuals …

The introduction of pneumococcal conjugate vaccines (PCVs) 7 and 13 into national
childhood immunization programs in the US in 2000 and 2010, respectively, proved to be …

This review provides an overview of the most important novel treatment strategies against
Streptococcus pneumoniae infections published over the past 10 years. The pneumococcus …

Streptococcus pneumoniae synthesizes> 100 types of capsular polysaccharides (CPSs).
While the diversity of the enzymes and transporters involved is enormous, it is not limitless …

Virtually all living cells are encased in glycans. They perform key cellular functions such as
immunomodulation and cell–cell recognition. Yet, how their composition and configuration …

Background Development of vaccines to prevent disease and death from Streptococcus
pneumoniae, and nontypeable Haemophilus influenzae (NTHi), the main pathogens that …

In the province of Alberta, Canada, invasive disease caused by Streptococcus pneumoniae
serogroup 20 (serotypes 20A/20B) has been increasing in incidence. Here, we characterize …

The goal of this study was to investigate the distribution of serotypes and clonal composition
of Streptococcus pneumoniae isolates causing invasive pneumococcal disease (IPD) in …

The structure of the exopolysaccharide capsule of Streptococcus pneumoniae is defined by
the genetic arrangement of the capsule operon allowing the unequivocal identification of the …

Streptococcus pyogenes and Streptococcus pneumoniae are important human pathogens
capable of causing invasive infections which need antimicrobial treatment. Aerococcus …